These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29788878)

  • 21. Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering.
    Guan D; Xuan B; Wang C; Long R; Jiang Y; Mao L; Kang J; Wang Z; Chow SF; Zhou Q
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical Cocrystals as an Opportunity to Modify Drug Properties: From the Idea to Application: A Review.
    Sokal A; Pindelska E
    Curr Pharm Des; 2018; 24(13):1357-1365. PubMed ID: 29278209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
    Cerreia Vioglio P; Chierotti MR; Gobetto R
    Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
    Kumar S; Gupta A; Mishra CK; Singh S
    Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.
    Kuminek G; Cao F; Bahia de Oliveira da Rocha A; Gonçalves Cardoso S; Rodríguez-Hornedo N
    Adv Drug Deliv Rev; 2016 Jun; 101():143-166. PubMed ID: 27137109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs.
    Chadha R; Saini A; Arora P; Bhandari S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(3):183-218. PubMed ID: 22577957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development.
    Gadade DD; Pekamwar SS
    Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties.
    Newman A; Zografi G
    J Pharm Sci; 2019 Mar; 108(3):1061-1080. PubMed ID: 30391302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability.
    Newman A; Reutzel-Edens SM; Zografi G
    J Pharm Sci; 2018 Jan; 107(1):5-17. PubMed ID: 28989014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing Dissolution Rate and Antibacterial Efficiency of Azithromycin through Drug-Drug Cocrystals with Paracetamol.
    Ul Islam N; Khan E; Naveed Umar M; Shah A; Zahoor M; Ullah R; Bari A
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form.
    Panzade PS; Shendarkar GR
    Drug Dev Ind Pharm; 2020 Oct; 46(10):1559-1568. PubMed ID: 32799687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities.
    Salem A; Khanfar E; Nagy S; Széchenyi A
    Int J Pharm; 2022 Jul; 623():121924. PubMed ID: 35738333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs.
    Bolla G; Sarma B; Nangia AK
    Chem Rev; 2022 Jul; 122(13):11514-11603. PubMed ID: 35642550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug.
    Devarapalli R; Indukuri A; Bollineni M; Mondal A; Reddy CM; Chennuru R
    Mol Pharm; 2021 Mar; 18(3):1138-1149. PubMed ID: 33528261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
    Zhang L; Kong D; Wang H; Jiao L; Zhao X; Song J; Yang D; Yang H; Yang S; Du G; Lu Y
    Molecules; 2021 May; 26(9):. PubMed ID: 34063645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.